Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | +2.52% | +16.07% | -21.59% |
Business Summary
Number of employees: 54
Managers
Managers | Title | Age | Since |
---|---|---|---|
Doug Onsi
CEO | Chief Executive Officer | 55 | 01/11/01 |
Chris Mirabelli
CHM | Chairman | 69 | 01/11/01 |
Jason Baum
CTO | Chief Tech/Sci/R&D Officer | 45 | 24/20/24 |
Michael Haas
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cynthia Sirard
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/12/01 |
Augustine Lawlor
COO | Chief Operating Officer | 67 | 01/16/01 |
General Counsel | 56 | 24/20/24 | |
Jonathan Miller
PRN | Corporate Officer/Principal | - | 01/20/01 |
Mark O’Mahony
PRN | Corporate Officer/Principal | 53 | 01/11/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
BRD | Director/Board Member | 72 | 01/16/01 |
Nissim Mashiach
BRD | Director/Board Member | 63 | 01/17/01 |
Chris Mirabelli
CHM | Chairman | 69 | 01/11/01 |
James Cavanaugh
BRD | Director/Board Member | 87 | 01/16/01 |
Thomas Dietz
BRD | Director/Board Member | 60 | 01/16/01 |
Doug Onsi
CEO | Chief Executive Officer | 55 | 01/11/01 |
Chris Richard
BRD | Director/Board Member | 54 | 17/23/17 |
Patricia Martin
BRD | Director/Board Member | 63 | 01/23/01 |
Richard Schilsky
BRD | Director/Board Member | 73 | 01/22/01 |
William Li
BRD | Director/Board Member | 61 | 01/17/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,261,130 | 32,139,737 ( 84.00 %) | 0 | 84.00 % |
Company contact information
Leap Therapeutics, Inc.
47 Thorndike Street Suite B1-1
02141, Cambridge
+617 714 0360
http://www.leaptx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.59% | 83.21M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- LPTX Stock
- Company Leap Therapeutics, Inc.